PMF1 and in situ carcinoma: Furthermore, in multivariable analysis, the authors found that among PMF-1 methylation status and clinical and pathological factors of sex, age, focality, tumor size, and concomitant CIS, only PMF-1 methylation was significantly associated with recurrence and progression.